In summary: BPC-157 is a promising compound for different cytoprotective uses It is not FDA approved for human use There is not some shadow cabal blocking the use of BPC-157 - Financial incentives make it so that BPC-157 is challenging to push through the regulatory process - It will likely never receive FDA approval, but will be available in some form as oral supplement or through compounding pharmacies, with some modification This is not medical advice
Since inhibition of DPP4 due to genetic deletion or use of DPP4 inhibitors was shown to elevate GLP-1/GIP levels in numerous studies, this effect is the main focus of developing therapeutic targets for treatment of T2DM
Matthew Anderson, an associate professor in genetics at the University of WisconsinMadison who is of Eastern Band of Cherokee Indians descent, argues that both individual donors and their communities should be consulted each time their fecal sample is used for a new research project
On the other hand, real-world data suggest that semaglutide use in obesity is associated with reduction in alcohol use disorders 24
2018 Apr;36(2)
We donate 10% of all our profits to veteran-focused charities, including the Glen Doherty Memorial Foundation